| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0009 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |